Hosted on MSN3h
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript
A press release announcing our results is currently available on our website at novavax.com and an audio archive of this ...
Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...
Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates
Novavax (NVAX) delivered earnings and revenue surprises of 12.64% and 47.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com on MSN2h
Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Novavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to ...
Åsa Manelius Named Managing Director of Novavax AB Site
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Åsa ...
Becker's Hospital Review1d
FDA lifts clinical hold on combined COVID-19-influenza vaccine trials
The FDA lifted a clinical hold that had been placed on Novavax's investigational new drug application after the company addressed concerns related to a serious adverse event reported in a phase 2 ...